Hudson Bay Capital Management »

Edgewise Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $407k 13k 31.50
2025-03-31 $2.2M 100k 22.00
2024-09-30 $1.1M 40k 26.69
2023-12-31 $13M 1.2M 10.94

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
Echostar Corp Note 3.875%11/3 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Flagstar Bank National Assoc Com New (FLG)
UnitedHealth Put Option (UNH)

View all positions for Hudson Bay Capital Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Paradigm Biocapital Advisors
Baker Bros. Advisors
BlackRock
Henderson Group
Novo A/S
Vanguard Group
Siren
Perceptive Advisors
Driehaus Capital Management
Vanguard Capital Management
Cormorant Asset Management
Braidwell
Morgan Stanley

View all funds holding Edgewise Therapeutics